Molecular Epidemiology of Ceftriaxone-Nonsusceptible Enterobacterales Isolates in an Academic Medical Center in the United States

Reporting Extended-Spectrum β-Lactamase Positivity May Reduce Carbapenem Overuse

(2019) Pranita D Tamma et al.   Open Forum Infectious Diseases

A Primer on AmpC Beta-Lactamases: Necessary Knowledge for an Increasingly Multidrug-Resistant World

(2019) Pranita D Tamma et al.   CLINICAL INFECTIOUS DISEASES

Beta-Lactam/Beta-Lactamase Inhibitor Therapy for Potential AmpC-Producing Organisms: A Systematic Review and Meta-Analysis

(2019) Matthew P Cheng et al.   Open Forum Infectious Diseases

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance

(2018) Patrick N. A. Harris et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27

(2017) Patrick N A Harris et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype

(2017) Edward R. Bevan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study

(2017) Maris S Arcilla et al.   LANCET INFECTIOUS DISEASES

Analysis of β-Lactamase Resistance Determinants in Enterobacteriaceae from Chicago Children: a Multicenter Survey

(2016) Latania K. Logan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Distribution of acquired AmpC β-lactamase genes in Sydney, Australia

(2015) Kaitlin A. Tagg et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae

(2015) Hadas Ofer-Friedman et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused byEnterobacter,CitrobacterorSerratiaspecies: a systematic review with meta-analysis

(2015) Patrick N. A. Harris et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial susceptibility reporting and treatment selection for AmpC-producing Enterobacteriaceae: what do microbiologists and infectious disease practitioners actually practice?

(2015) P.N.A. Harris et al.   PATHOLOGY

Clinical and Microbiologic Characteristics of Cephalosporin-Resistant Escherichia coli at Three Centers in the United States

(2012) Yoon Soo Park et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of a DNA Microarray (Check-MDR CT102) for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum  -Lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 Carbapenemases

(2011) T. Naas et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical Features and Molecular Epidemiology of CMY‐Type β‐Lactamase–ProducingEscherichia coli

(2009) Hanna E. Sidjabat et al.   CLINICAL INFECTIOUS DISEASES

Cephalosporin MIC Distribution of Extended-Spectrum- -Lactamase- and pAmpC-Producing Escherichia coli and Klebsiella Species

(2009) P. C. Kohner et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Prevalence and Mechanisms of Broad-Spectrum  -Lactam Resistance in Enterobacteriaceae: a Children's Hospital Experience

(2008) X. Qin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

(2008) Johann DD Pitout et al.   LANCET INFECTIOUS DISEASES